Respiratory Medicine

Journal

Publication Venue For

  • Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.  149:52-58. 2019
  • NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.  140:87-93. 2018
  • Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.  139:72-78. 2018
  • A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival.  115:33-38. 2016
  • Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.  111:30-38. 2016
  • A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.  110:66-72. 2016
  • Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis.  109:1001-1011. 2015
  • Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.  108:1469-1480. 2014
  • Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD.  108:366-375. 2014
  • Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.  108:181-188. 2014
  • Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.  108:1171-1179. 2014
  • Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease.  106:1134-1138. 2012
  • Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD.  105:1322-1330. 2011
  • Geographic disparity in COPD hospitalization rates among the Texas population.  105:734-739. 2011
  • Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease.  102:999-1003. 2008
  • Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis.  102:1080-1088. 2008
  • Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.  102:681-689. 2008
  • Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease.  100:1110-1116. 2006
  • The FEV1/FEV6 predicts lung function decline in adult smokers.  96:444-449. 2002
  • Continuous positive airway pressure ventilation for respiratory failure associated with Pneumocystis carinii pneumonia.  85:133-138. 1991
  • Cavitary lung disease caused by Mycobacterium avium-intracellulare in AIDS patients.  84:409-411. 1990
  • International Standard Serial Number (issn)

  • 0954-6111
  • Electronic International Standard Serial Number (eissn)

  • 1532-3064